At AHA 2024, the safety of GLP-1R agonists in heart failure and chronic kidney disease (CKD) patients was discussed.

An intensive treatment approach to lowering high systolic blood pressure in people with Type 2 diabetes led to a reduced risk ...

Rhythm Technologies announced new research emphasizing the clinical and health-economic advantages of its Zio LTCM system.

This study links rare genetic variants to type 2 diabetes risk, emphasizing their role in monogenic diabetes and potential ...

In a landmark announcement at Shanghai Ruijin Hospital on Nov 13, the China Metabolic Analytics Project (ChinaMAP) revealed ...

With an increasing burden of diabetes in Singapore, digital innovations, research can help diabetics manage better. Read more ...